About LCU CME Meetings Meet The Professors Patterns of Care Patient Projects Other Tumor Types About Us
You are here: Home: LCU Think Tank 1 | 2006: Section 2: Select publications

SELECT PUBLICATIONS

Lilenbaum R et al. Randomized phase II trial of single agent erlotinib vs standard chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2. Presentation. Proc ASCO 2006;Abstract 7022.

Lilenbaum RC et al. Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: The Cancer and Leukemia Group B (study 9730). J Clin Oncol 2005;23(1):190-6. Abstract


Table of Contents Top of Page

Table of Contents

Topics

Section 1: Bevacizumab Combined with Chemotherapy as First-Line Therapy of Advanced Non-small Cell Lung Cancer (NSCLC)
- Select publications

Section 2: Treatment for Patients with Poor Performance Status
- Select publications

Section 3: Clinical Use of EGFR Tyrosine Kinase Inhibitors (TKI)
- Select publications

Section 4: Adjuvant Systemic Therapy for NSCLC
- Select publications

Section 5: Management of Stage III NSCLC
- Select publications

CME Information

Faculty Disclosures

Editor's Office
LCU Media Center
Download PDF
Listen to Audio Files
Read Previous Issues
Terms of Use and General Disclaimer
Copyright © 2006 Research To Practice. All Rights Reserved.